Loading...

We've got a brand new version of Simply Wall St! Try it out

Neolife

ENXTPA:ALNLF
Snowflake Description

Imperfect balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ALNLF
ENXTPA
€4M
Market Cap
  1. Home
  2. FR
  3. Commercial Services
Company description

Neolife SA provides building solutions. Its solutions enable architects, landscapists, design offices, and building technicians to meet environmental specification packages for HQE (France), BREEAM, and LEED projects for individual and multi-unit housing, commercial buildings, and urban spaces. The last earnings update was 73 days ago. More info.


Add to Portfolio Compare Print
  • Neolife has significant price volatility in the past 3 months.
ALNLF Share Price and Events
7 Day Returns
-3.8%
ENXTPA:ALNLF
-2.2%
FR Professional Services
-2.1%
FR Market
1 Year Returns
-19.6%
ENXTPA:ALNLF
31.5%
FR Professional Services
16.4%
FR Market
ALNLF Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Neolife (ALNLF) -3.8% -22.4% -19.6% -19.6% -86.4% -98.2%
FR Professional Services -2.2% 2.5% 4.9% 31.5% 62.1% 100.5%
FR Market -2.1% -0.1% 3% 16.4% 29.5% 44%
1 Year Return vs Industry and Market
  • ALNLF underperformed the Professional Services industry which returned 31.5% over the past year.
  • ALNLF underperformed the Market in France which returned 16.4% over the past year.
Price Volatility
ALNLF
Industry
5yr Volatility vs Market

Value

 Is Neolife undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Neolife. This is due to cash flow or dividend data being unavailable. The share price is €0.1005.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Neolife's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Neolife's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ENXTPA:ALNLF PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in EUR €-0.04
ENXTPA:ALNLF Share Price ** ENXTPA (2019-12-05) in EUR €0.1
France Professional Services Industry PE Ratio Median Figure of 11 Publicly-Listed Professional Services Companies 15.16x
France Market PE Ratio Median Figure of 406 Publicly-Listed Companies 17.81x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Neolife.

ENXTPA:ALNLF PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ENXTPA:ALNLF Share Price ÷ EPS (both in EUR)

= 0.1 ÷ -0.04

-2.63x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Neolife is loss making, we can't compare its value to the FR Professional Services industry average.
  • Neolife is loss making, we can't compare the value of its earnings to the France market.
Price based on expected Growth
Does Neolife's expected growth come at a high price?
Raw Data
ENXTPA:ALNLF PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -2.63x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
France Professional Services Industry PEG Ratio Median Figure of 7 Publicly-Listed Professional Services Companies 1.12x
France Market PEG Ratio Median Figure of 254 Publicly-Listed Companies 1.54x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Neolife, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Neolife's assets?
Raw Data
ENXTPA:ALNLF PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in EUR €0.05
ENXTPA:ALNLF Share Price * ENXTPA (2019-12-05) in EUR €0.1
France Professional Services Industry PB Ratio Median Figure of 14 Publicly-Listed Professional Services Companies 1.37x
France Market PB Ratio Median Figure of 595 Publicly-Listed Companies 1.44x
ENXTPA:ALNLF PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ENXTPA:ALNLF Share Price ÷ Book Value per Share (both in EUR)

= 0.1 ÷ 0.05

2x

* Primary Listing of Neolife.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Neolife is overvalued based on assets compared to the FR Professional Services industry average.
X
Value checks
We assess Neolife's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Professional Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Professional Services industry average (and greater than 0)? (1 check)
  5. Neolife has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Neolife expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Neolife has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
11.2%
Expected Professional Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Neolife expected to grow at an attractive rate?
  • Unable to compare Neolife's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Neolife's earnings growth to the France market average as no estimate data is available.
  • Unable to compare Neolife's revenue growth to the France market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
ENXTPA:ALNLF Future Growth Rates Data Sources
Data Point Source Value (per year)
France Professional Services Industry Earnings Growth Rate Market Cap Weighted Average 11.2%
France Professional Services Industry Revenue Growth Rate Market Cap Weighted Average 5.8%
France Market Earnings Growth Rate Market Cap Weighted Average 11.6%
France Market Revenue Growth Rate Market Cap Weighted Average 4.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ENXTPA:ALNLF Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ENXTPA:ALNLF Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-06-30 7 -2
2019-03-31 7 -2
2018-12-31 6 -2
2018-06-30 8 -1 -2
2018-03-31 8 -1 -2
2017-12-31 7 -1 -2
2017-09-30 6 -1 -3
2017-06-30 6 -1 -4
2017-03-31 5 -1 -3
2016-12-31 5 -1 -3
2016-09-30 5 -2 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Neolife is high growth as no earnings estimate data is available.
  • Unable to determine if Neolife is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ENXTPA:ALNLF Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Neolife Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ENXTPA:ALNLF Past Financials Data
Date (Data in EUR Millions) EPS *
2019-06-30 -0.04
2019-03-31 -0.04
2018-12-31
2018-06-30 -0.10
2018-03-31 -0.10
2017-12-31 -0.10
2017-09-30 -0.14
2017-06-30 -0.18
2017-03-31 -0.19
2016-12-31 -0.19
2016-09-30 -0.15

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Neolife will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Neolife's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Commercial Services companies here
  2. Neolife's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Neolife's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the France market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the France market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Neolife has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Neolife performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Neolife's growth in the last year to its industry (Professional Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Neolife does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Neolife's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Neolife's 1-year growth to the FR Professional Services industry average as it is not currently profitable.
Earnings and Revenue History
Neolife's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Neolife Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ENXTPA:ALNLF Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 6.68 -1.56 -0.29
2019-03-31 6.53 -1.82 -0.14
2018-12-31 6.39 -2.09
2018-06-30 7.91 -2.17 3.39
2018-03-31 7.54 -2.14 3.42
2017-12-31 7.16 -2.12 3.45
2017-09-30 6.42 -2.84 3.31
2017-06-30 5.67 -3.56 3.16
2017-03-31 5.18 -3.35 3.02
2016-12-31 4.68 -3.14 2.88
2016-09-30 4.57 -2.19 3.05
2016-06-30 4.46 -1.25 3.21
2016-03-31 4.35 -1.42 3.32
2015-12-31 4.25 -1.58 3.44

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Neolife has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Neolife has efficiently used its assets last year compared to the FR Professional Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Neolife improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Neolife's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Professional Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Neolife has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Neolife's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Neolife's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Neolife is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Neolife's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Neolife's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Neolife Company Filings, last reported 5 months ago.

ENXTPA:ALNLF Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 2.05 1.40 0.93
2019-03-31 2.05 1.40 0.93
2018-12-31
2018-06-30 1.71 1.73 0.30
2018-03-31 1.71 1.73 0.30
2017-12-31 1.81 2.24 0.69
2017-09-30 1.81 2.24 0.69
2017-06-30 1.27 2.63 0.69
2017-03-31 1.27 2.63 0.69
2016-12-31 1.27 2.22 0.31
2016-09-30 1.27 2.22 0.31
2016-06-30 2.51 2.41 0.14
2016-03-31 2.51 2.41 0.14
2015-12-31 2.74 2.34 0.67
  • Neolife's level of debt (68.6%) compared to net worth is high (greater than 40%).
  • Unable to establish if Neolife's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on Neolife's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess Neolife's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Neolife has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Neolife's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Neolife dividends.
If you bought €2,000 of Neolife shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Neolife's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Neolife's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ENXTPA:ALNLF Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
France Professional Services Industry Average Dividend Yield Market Cap Weighted Average of 7 Stocks 1.6%
France Market Average Dividend Yield Market Cap Weighted Average of 310 Stocks 2.9%
France Minimum Threshold Dividend Yield 10th Percentile 0.9%
France Bottom 25% Dividend Yield 25th Percentile 1.5%
France Top 25% Dividend Yield 75th Percentile 4.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Neolife has not reported any payouts.
  • Unable to verify if Neolife's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Neolife's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Neolife has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Neolife's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Neolife afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Neolife has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Neolife's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • Neolife has no CEO, or we have no data on them.
Management Team
Board of Directors
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Neolife's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Neolife has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Did You Manage To Avoid Neolife's (EPA:ALNLF) Devastating 91% Share Price Drop?

And over the last year the share price fell 41%, so we doubt many shareholders are delighted. … See our latest analysis for Neolife Given that Neolife didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. … In the last three years, Neolife saw its revenue grow by 21% per year, compound.

Simply Wall St -

Can We See Significant Institutional Ownership On The Neolife SA (EPA:ALNLF) Share Register?

Generally speaking, as a company grows, institutions will increase their ownership. … Neolife is not a large company by global standards. … Our analysis of the ownership of the company, below, shows that.

Simply Wall St -

How Financially Strong Is Neolife SA (EPA:ALNLF)?

Neolife SA (EPA:ALNLF) is a small-cap stock with a market capitalization of €3.5m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health.

Simply Wall St -

What You Must Know About Neolife SA's (EPA:ALNLF) Financial Strength

Neolife SA (EPA:ALNLF) is a small-cap stock with a market capitalization of €5.43m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health.

Simply Wall St -

Did Neolife SA's (EPA:ALNLF) Recent Earnings Growth Beat The Trend?

When Neolife SA (ENXTPA:ALNLF) released its most recent earnings update (31 December 2017), I compared it against two factor: its historical earnings track record, and the performance of its industry peers on average. … View our latest analysis for Neolife Were ALNLF's earnings stronger than its past performances and the industry? … I like to use data from the most recent 12 months, which either annualizes the most recent 6-month earnings update, or in some cases, the most recent annual report is already the latest available financial data.

Simply Wall St -

Who Are The Top Investors In Neolife SA (EPA:ALNLF)?

Check out our latest analysis for Neolife ENXTPA:ALNLF Ownership_summary Apr 10th 18 Institutional Ownership Institutional investors transact in large blocks which can influence the momentum of stock prices, at least in the short-term, especially when there is a low level of public shares available on the market to trade. … This level of ownership gives retail investors the power to sway key policy decisions such as board composition, executive compensation, and potential acquisitions. … Thus, potential investors should look into these business relations and check how it can impact long-term shareholder returns.Next Steps: With a low level of institutional ownership, investors in ALNLF need not worry about non-fundamental factors such as ownership structure causing large impact on stock prices.

Simply Wall St -

When Will Neolife SA (EPA:ALNLF) Run Out Of Money?

Additional cash raising may dilute the value of your shares, and since Neolife is currently burning more cash than it is making, it’s likely the business will need funding for future growth. … How fast Neolife runs down its cash supply over time is known as the cash burn rate. … Now you know that even if the company was to continue to shrink its opex at this rate, it will not be able to sustain its operations given the current level of cash reserves.

Simply Wall St -

What Investors Should Know About Neolife SA's (EPA:ALNLF) Financial Strength

Given that ALNLF is not presently profitable, it’s essential to assess the current state of its operations and pathway to profitability. … With this debt payback, the current cash and short-term investment levels stands at €308.42K for investing into the business. … Though, since ALNLF is currently unprofitable, sustainability of its current state of operations becomes a concern.

Simply Wall St -

Company Info

Description

Neolife SA provides building solutions. Its solutions enable architects, landscapists, design offices, and building technicians to meet environmental specification packages for HQE (France), BREEAM, and LEED projects for individual and multi-unit housing, commercial buildings, and urban spaces. The company also offers claddings, insulated facade systems, outdoor joineries, covering systems, partitions and linings, movable walls, terrace decking and systems, and privacy screens. In addition, it provides fencings, water walls, street furniture, walkways and other landscaping features, garages, carports, summer houses/conservatories, and recycled materials. The company was incorporated in 2012 and is headquartered in Limonest, France.

Details
Name: Neolife SA
ALNLF
Exchange: ENXTPA
Founded: 2012
€4,229,765
42,382,417
Website: http://www.neolife-solutions.com
Address: Neolife SA
304, RN6 - Celtic Parc Batiment Avalon II,
Limonest,
Rhône-Alpes, 69760,
France
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ENXTPA ALNLF Share Capital Euronext Paris FR EUR 23. Dec 2013
Number of employees
Current staff
Staff numbers
15
Neolife employees.
Industry
Research and Consulting Services
Commercial Services
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/12/05 21:56
End of day share price update: 2019/12/05 00:00
Last earnings filing: 2019/09/23
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.